NCT03762499 Hypertension Management in Young Adults Personalised by Echocardiography and Clinical Outcome.
| NCT ID | NCT03762499 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Oxford |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 750 participants |
| Start Date | 2018-10-02 |
| Primary Completion | 2028-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 750 participants in total. It began in 2018-10-02 with a primary completion date of 2028-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
HyperEcho is a multi-centre longitudinal observational study, to investigate whether baseline transthoracic echocardiography along with routine data collected in the hypertension clinic can guide clinicians to better manage, and improve risk stratification for cardiovascular disease in young adults with hypertension. Participants are characterised as young adult patients aged between 18 to 40 years old and referred to the hypertension clinic to manage their blood pressure. The study visit will be carried out during the planned routine visit of the participants to the hypertension clinics of NHS trusts within England. Routine data will be collected by the assigned nurse for the hypertension clinic as part of the clinical service, and research participation will not affect the clinical progress of the participant. The additional research component to the clinic will be asking the participants for their consent to undergo a research echocardiography scan if it has not been a part of their clinical assessment. Participants will also be asked to consent to the use of their data that has been collected in the hypertension clinic, such as; referral letters, medical history, 24-hour blood pressure monitoring report, ECG, blood samples, body fat composition, and dietary questionnaire. In addition to this, participants will be asked to consent to further review of their data and medical notes during their follow up visits (up to 10 years).
Eligibility Criteria
Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study. * Male or Female, aged 18 - 40 years (at the time of their appointment at the hypertension clinic). * Referred for a Hypertension Clinic in England. Exclusion Criteria: * Unable or unwilling to give valid consent for participation in the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03762499 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03762499 currently recruiting?
Yes, NCT03762499 is actively recruiting participants. Contact the research team at maryam.alsharqi@cardiov.ox.ac.uk for enrollment information.
Where is the NCT03762499 trial being conducted?
This trial is being conducted at Oxford, United Kingdom.
Who is sponsoring the NCT03762499 clinical trial?
NCT03762499 is sponsored by University of Oxford. The trial plans to enroll 750 participants.